Pain in Children Who Have Life-Limiting Conditions

Child and Adolescent Psychiatric Clinics of North America

Volumn 15, Issue 3, 2006, Pages 657-682

  McCulloch, Renée ^a   Collins, John J ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BISPHOSPHONIC ACID DERIVATIVE; BOTULINUM TOXIN A; CALCITONIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CODEINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; FENTANYL; HYDROMORPHONE; KETAMINE; LIDOCAINE; METHADONE; MIDAZOLAM; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; OPIATE; OXYCODONE; PARACETAMOL; PHENOTHIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUPUNCTURE ANALGESIA; BLEEDING; BONE PAIN; CANCER PAIN; CARDIOTOXICITY; CAREGIVER; CHECKLIST; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; CYSTIC FIBROSIS; DEATH; DREAM; DRUG SAFETY; DRUG TOLERABILITY; ETHICS; GASTROINTESTINAL HEMORRHAGE; HALLUCINATION; HEALTH CARE; HEALTH PRACTITIONER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; MORBIDITY; MUCOSA INFLAMMATION; MUSCULOSKELETAL PAIN; NAUSEA AND VOMITING; NEUROMUSCULAR DISEASE; NEUROPATHIC PAIN; NOCICEPTION; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PEDIATRICS; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PRURITUS; PSYCHOTHERAPY; RATING SCALE; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; THROMBOCYTE DYSFUNCTION; TRANSCUTANEOUS NERVE STIMULATION; URINE RETENTION; VISUAL ANALOG SCALE;

ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN; CHILD; COGNITION DISORDERS; CRITICAL ILLNESS; HUMANS; NARCOTICS; NEOPLASMS; PAIN; PAIN MEASUREMENT;

EID: 33746908604     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2006.02.001     Document Type: Review

References (117)

1. The world health report [pamphlet] (1995), World Health Organization, Geneva (Switzerland)
2. Cooley C., Adeodu S., Aldred H., et al. Paediatric palliative care: a lack of research-based evidence. Int J Palliat Nurs 6 7 (2000) 346-351
3. The Association for Children with Life-Threatening or Terminal Conditions and Their Families and the Royal College of Paediatrics and Child Health. A guide to the development of children's palliative care services (2003), The Association for Children with Life-Threatening or Terminal Conditions and Their Families, Bristol, Great Britain
4. Field M.J., and Behman R.E. When children die: improving palliative and end-of-life care for children and their families (2003), National Academic Press, Washington, DC
5. Miser A.W., Dothage P., Wesley R.A., et al. The prevalence of pain in a pediatric and young adult population. Pain 29 (1987) 265-266
6. Ljungman G., Gordh T., Sorensen S., et al. Pain in paediatric oncology: interviews with children, adolescents and their parents. Acta Paediatr 88 6 (1999) 623-630
7. Ljungman G., Gordh T., Sorensen S., et al. Pain variations during cancer treatment in children: a descriptive survey. Pediatr Hematol Oncol 17 3 (2000) 211-221
8. Van Cleve L., Bossert E., Beecroft P., et al. The pain experience of children with leukemia during the first year after diagnosis. Nurs Res 53 1 (2004) 1-10
9. Miser A.W., McCalla J., Dothage J.A., et al. Pain as a presenting symptom in children and young adults with newly diagnosed malignancy. Pain 29 1 (1987) 85-90
10. Collins J.J., Devine T.D., Dick G.S., et al. The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12. J Pain Symptom Manage 23 1 (2002) 10-16
11. Lolekha R., Chanthavanich P., Limkittikul K., et al. Pain: a common symptom in human immunodeficiency virus-infected Thai children. Acta Paediatr 93 7 (2004) 891-898
12. Koh J.L., Harrison D., Palermo T.M., et al. Assessment of acute and chronic pain symptoms in children with cystic fibrosis. Pediatric Pulmonol 40 4 (2005) 330-335
13. Ravilly S., Robinson W., Suresh S., et al. Chronic pain in cystic fibrosis. Pediatrics 98 4 (1996) 741-747
14. Robinson W.M., Ravilly S., Berde C., et al. End-of-life care in cystic fibrosis. Pediatrics 100 2 (1997) 205-209
15. Anand K.J.S., and Craig K.D. New perspectives on the definition of pain. Pain 67 1 (1996) 3-6
16. Carter B., McArthur E., and Cunliffe M. Dealing with uncertainty: parental assessment of pain in their children with profound special needs. J Adv Nurs 38 5 (2002) 449-457
17. Breau L.M., Camfield C.S., McGrath P.J., et al. Risk factors for pain in children with severe cognitive impairments. Dev Med Child Neurol 46 6 (2004) 364-371
18. Nolan J., Chalkiadis G.A., Low J., et al. Anaesthesia and pain management in cerebral palsy. Anaesthesia 55 1 (2000) 32-41
19. Hunt A.M., and Burne R. Medical and nursing problems of children with neurodegenerative disease. Palliat Med 9 (1995) 19-26
20. Spencer J.D. Reconstruction of dislocated hips in children with cerebral palsy. Br Med J 318 7190 (1999) 1021-1022
21. Houlihan C.M., O'Donnell M., Conaway M., et al. Bodily pain and health-related quality of life in children with cerebral palsy. Dev Med Child Neurol 46 5 (2004) 305-310
22. Stallard P., Williams L., Lenton S., et al. Pain in cognitively impaired, non-communicating children. Arch Dis Child 85 6 (2001) 460-462
23. Hunt A.M. A survey of signs, symptoms and symptom control in 30 terminally ill children. Dev Med Child Neurol 32 4 (1990) 341-346
24. Carter B.S., Howenstein M., Gilmer M.J., et al. Circumstances surrounding the deaths of hospitalized children: opportunities for pediatric palliative care. Pediatrics 114 3 (2004) 361-366
25. Eccleston C., Morley S., Williams A., et al. Review: psychological interventions reduce the severity and frequency of chronic pain in children and adolescents. Evid Based Med 8 3 (2003) 89
26. Contro N., Larson J., Scofield S., et al. Family perspectives on the quality of pediatric palliative care. Arch Pediatr Adolesc Med 156 1 (2002) 14-19
27. Wolfe J. Suffering in children at the end of life: recognizing an ethical duty to palliate. J Clin Ethics 11 2 (2000) 157-163
28. Champion G.D., Goodenough B., von Baeyer C., et al. Measurement of pain by self-report. In: Finley G.A., and McGrath P.J. (Eds). Measurement of pain in infants and children (1998), IASP Press, Seattle (WA) 5-20
29. Hicks C.L., von Baeyer C.L., Spafford P.A., et al. The Faces Pain Scale revised: toward a common metric in pediatric pain measurement. Pain 93 2 (2001) 173-183
30. Hunter M., McDowell L., Hennessy R., et al. An evaluation of the Faces Pain Scale with young children. J Pain Symptom Manage 20 2 (2000) 122-129
31. McGrath P.A., and Gillespie J. Pain assessment in children and adolescents. In: Turck D.C., and Melzack R. (Eds). Handbook of pain assessment. 2nd edition (2001), Guildford Press, New York 97-119
32. Shih A.R., and von Baeyer C.L. Preschool children's seriation of pain faces and happy faces in the Affective Facial Scale. Psychol Rep 74 2 (1994) 659-665
33. St-Laurent-Gagnon T., Bernard-Bonnin A.C., and Villeneuve E. Pain evaluation in preschool children and their parents. Acta Paediatr 88 4 (1999) 422-427
34. McGrath P.J., and Unruh A.M. Measurement and assessment of paediatric pain. In: Wall P.D., and Melzack R. (Eds). Textbook of pain. 4th edition (1999), Churchill Livingstone, New York 371-384
35. Grunau R.V.E., and Craig K.D. Pain expression in neonates: facial action and cry. Pain 28 3 (1987) 395-410
36. Merkel S.I., Voepel-Lewis T., Shayevitz J.R., et al. The FLACC a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 23 3 (1997) 293-297
37. Ramelet A.S., Abu-Saad H.H., Rees N., et al. The challenges of pain measurement in critically ill young children: a comprehensive review. Aust Crit Care 17 1 (2004) 33-45
38. Biersdorff K.K. Incidence of significantly altered pain experience among individuals with developmental disabilities. Am J Ment Retard 98 5 (1994) 619-631
39. Stallard P., Williams L., Velleman R., et al. Brief report: behaviors identified by caregivers to detect pain in noncommunicating children. J Pediatr Psychol 27 2 (2002) 209-214
40. Breau L.M., McGrath P.J., Camfield C., et al. Preliminary validation of an observational pain checklist for persons with cognitive impairments and inability to communicate verbally. Dev Med Child Neurol 42 9 (2000) 609-616
41. Breau L.M., Camfield C., McGrath P.J., et al. Measuring pain accurately in children with cognitive impairments: refinement of a caregiver scale. J Pediatr 138 5 (2001) 721-727
42. Breau L.M., Finley G.A., McGrath P.J., et al. Validation of the Non-communicating Children's Pain Checklist-postoperative version. Anesthesiology 96 3 (2002) 528-535 [Erratum appears in Anesthesiology 2002;97(3):769.]
43. Gauvain-Piquard A., Rodary C., Rezvani A., et al. The development of the DEGR(R): a scale to assess pain in young children with cancer. Eur J Pain 3 2 (1999) 165-176
44. Collins J.J., Byrnes M.E., Dunkel I.J., et al. The measurement of symptoms in children with cancer. J Pain Symptom Manage 19 5 (2000) 363-377
45. McCallum D.E., Byrne P., and Bruera E. How children die in hospital. J Pain Symptom Manage 20 (1920) 417-423
46. Hodgkins M., Albert D., and Daltroy L. Comparing patients' and their physicians' assessments of pain. Pain 23 3 (1985) 273-277
47. Janse A.J., Sinnema G., Uiterwaal C.S.P.M., et al. Quality of life in chronic illness: perceptions of parents and paediatricians. Arch Dis Child 90 5 (2005) 486-491
48. Berde C.B., and Sethna N.F. Analgesics for the treatment of pain in children. N Engl J Med 347 14 (2002) 1094-1103
49. Korpela R., Korvenoja P., and Meretoja O.A. Morphine-sparing effect of acetaminophen in pediatric day-case surgery. Anesthesiology 91 2 (1999) 442-447
50. Murat I., Baujard C., Foussat C., et al. Tolerance and analgesic efficacy of a new i.v. paracetamol solution in children after inguinal hernia repair. Paediatr Anaesth 15 8 (2005) 663-670
51. Birmingham P.K., Tobin M.J., Fisher D.M., et al. Initial and subsequent dosing of rectal acetaminophen in children: a 24-hour pharmacokinetic study of new dose recommendations. Anesthesiology 94 3 (2001) 385-389
52. Vetter T.R., and Heiner E.J. Intravenous ketorolac as an adjuvant to pediatric patient-controlled analgesia with morphine. J Clin Anesth 6 2 (1994) 110-113
53. Tramer M.R., Williams J.E., Carroll D., et al. Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Acta Anaesth Scand 42 1 (1998) 71-79
54. Tramer M.R., Moore R.A., Reynolds D.J., et al. Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. Pain 85 1-2 (2000) 169-182
55. Goldstein J.L., Silverstein F.E., Agrawal N.M., et al. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 95 7 (2000) 1681-1690
56. Leese P.T., Hubbard R.C., Karim A., et al. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol 40 2 (2000) 124-132
57. Vielhaber A., and Portenoy R.K. Advances in cancer pain management. Hematol Oncol Clin North Am 16 3 (2002) 527-541
58. Caraceni A., Portenoy R.K., Ashby M.A., et al. An international survey of cancer pain characteristics and syndromes. Pain 82 3 (1999) 263-274
59. Wiffen P., Collins S., McQuay H., et al. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 20 (2005) CD001133
60. Saarto T., and Wiffen P.J. Antidepressants for neuropathic pain. Cochrane Database Syst Rev (2005)
61. Joranson D.E., Ryan K.M., Gilson A.M., et al. Trends in medical use and abuse of opioid analgesics. JAMA 283 13 (2000) 1710-1714
62. Caran E.M.M., Dias C.G., Seber A., et al. Clinical aspects and treatment of pain in children and adolescents with cancer. Pediatr Blood Cancer 45 7 (2005) 925-932
63. Ellis J.A., McCarthy P., Hershon L., et al. Pain practices: a cross-Canada survey of pediatric oncology centers. J Pediatr Oncol Nurs 1 (2003) 26-35
64. Berde C.B., Ablin A.R., Glazer J., et al. American Academy of Pediatrics: report of the subcommittee on disease-related pain in childhood cancer. Pediatrics 86 (1990) 818-825
65. McGrath P.A. Development of the World Health Organization Guidelines on Cancer Pain Relief and Palliative Care in Children. J Pain Symptom Manage 12 (1996) 87-92
66. Ljungman G., Kreuger A., Gordh T., et al. Treatment of pain in pediatric oncology: a Swedish nationwide survey. Pain 68 2-3 (1996) 385-394
67. Williams D.G., Patel A., and Howard R.F. Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth 89 6 (2002) 839-845
68. Bouwmeester N.J., Anderson B.J., Tibboel D., et al. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Br J Anaesth 92 2 (2004) 208-217
69. Kart T., Christrup L.L., and Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: part 2-clinical use. Paediatr Anaesth 7 2 (1997) 93-101
70. Bhat R., bu-Harb M., Chari G., et al. Morphine metabolism in acutely ill preterm newborn infants. J Pediatr 120 5 (1992) 795-799
71. Hunt A., Joel S., Dick G., et al. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain. J Pediatr 135 1 (1999) 47-55
72. Hain R.D., Hardcastle A., Pinkerton C.R., et al. Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children. Br J Clin Pharmacol 48 1 (1999) 37-42
73. Bruera E.B. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol 16 10 (1998) 3222-3229
74. Lugo R.A., and Kern S.E. The pharmacokinetics of oxycodone. J Pain Palliat Care Pharmacother 18 4 (2004) 17-30
75. Attia M.W. Buccal oxycodone reduced pain more than placebo in children with acute undifferentiated abdominal pain: commentary. Evid Based Med 10 5 (2005) 147
76. Kokki H., Lintula H., Vanamo K., et al. Oxycodone vs placebo in children with undifferentiated abdominal pain: a randomized, double-blind clinical trial of the effect of analgesia on diagnostic accuracy. Arch Pediatr Adolesc Med 159 4 (2005) 320-325
77. Lawlor P., Turner K., Hanson J., et al. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain 72 1-2 (1997) 79-85
78. Moriarty M., McDonald C.J., and Miller A.J. A randomised crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain. Journal of Clinical Research 2 (1999) 1-8
79. Collins J.J., Geake J., Grier H.E., et al. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. J Pediatr 129 5 (1996) 722-728
80. Quigley C. Hydromorphone for acute and chronic pain. Cochrane Database Syst Rev (2005)
81. Collins J.J., Dunkel I.J., Gupta S.K., et al. Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. J Pediatr 134 3 (1999) 319-323
82. Noyes M., and Irving H. The use of transdermal fentanyl in pediatric oncology palliative care. Am J Hosp Palliat Care 18 6 (2001) 411-416
83. Hunt I.S., Goldman A., Devine T.B., et al. Transdermal fentanyl for pain relief in a paediatric palliative care population. Palliat Med 15 (2001) 405-412
84. Koren G., Crean P., and Goresky G.V. Pharmacokinetics of fentanyl in children with renal disease. Res Commun Chem Pathol Pharmacol 46 3 (1984) 371-379
85. Finkel J.C., Finley A., Greco C., et al. Transdermal fentanyl in the management of children with chronic severe pain: results from an international study. Cancer 104 12 (2005) 2847-2857
86. Hanks G.W., Nugent M., Higgs C.M.B., et al. Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study. Palliat Med 18 8 (2004) 698-704
87. Bruera E., and Sweeney C. Methadone use in cancer patients with pain: a review. J Palliat Med 5 1 (2002) 127-138
88. Dale O., Hoffer C., Sheffels P., et al. Disposition of nasal, intravenous, and oral methadone in healthy volunteers. Clin Pharmacol Ther 72 5 (2002) 536-545
89. Dale O., Sheffels P., and Kharasch E.D. Bioavailabilities of rectal and oral methadone in healthy subjects. Br J Clin Pharmacol 58 2 (2004) 156-162
90. Shir Y., Shenkman Z., Shavelson V., et al. Oral methadone for the treatment of severe pain in hospitalized children: a report of five cases. Clin J Pain 14 4 (1998) 350-353
91. Sabatowski R., Kasper S.M., and Radbruch L. Patient-controlled analgesia with intravenous L-methadone in a child with cancer pain refractory to high-dose morphine. J Pain Symptom Manage 23 1 (2002) 3-5
92. Miser A.W., and Miser J.S. The use of oral methadone to control moderate and severe pain in children and young adults with malignancy. Clin J Pain 1 4 (1985) 243-248
93. Dix P., Martindale S., and Stoddart P.A. Double-blind randomized placebo-controlled trial of the effect of ketamine on postoperative morphine consumption in children following appendicectomy. Paediatr Anaesth 13 5 (2003) 422-426
94. Klepstad P., Maurset A., Moberg E.R., et al. Evidence of a role for NMDA receptors in pain perception. Eur J Pharmacol 187 3 (1990) 513-518
95. Fitzgibbon E.J., and Viola R. Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit. J Palliat Med 8 1 (2005) 49-57
96. Mercadante S., Arcuri E., Tirelli W., et al. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage 20 4 (2000) 246-252
97. Weinbroum A.A. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg 96 3 (2003) 789-795
98. Bell R., Eccleston C., and Kalso E. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 1 (2003) CD003351
99. Bruera E., Brenneis C., Michaud M., et al. Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer 62 (1988) 407-411
100. Geldner G., Hubmann M., Knoll R., et al. Comparison between three transmucosal routes of administration of midazolam in children. Paediatr Anaesth 7 2 (1997) 103-109
101. Saroyan J.M., Schechter W.S., Tresgallo M.E., et al. Role of intraspinal analgesia in terminal pediatric malignancy. J Clin Oncol 23 6 (2005) 1318-1321
102. Collins J.J., Grier H.E., Kinney H.C., et al. Control of severe pain in children with terminal malignancy. J Pediatr 126 4 (1995) 653-657
103. Collins J.J., Grier H.E., Sethna N.F., et al. Regional anesthesia for pain associated with terminal pediatric malignancy. Pain 65 1 (1996) 63-69
104. Charron M., Brown M., Rowland P., et al. Pain palliation with strontium-89 in children with metastatic disease. Med Pediatr Oncol 26 6 (1996) 393-396
105. Paulino A.C. Palliative radiotherapy in children with neuroblastoma. Pediatr Hematol Oncol 20 2 (2003) 111-117
106. Mercadante S., Radbruch L., Caraceni A., et al. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 94 3 (2002) 832-839
107. Portenoy R.K., Payne D., and Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 81 1-2 (1999) 129-134
108. Caraceni A., Martini C., Zecca E., et al. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med 18 3 (2004) 177-183
109. Berde C.B., Lehn B.M., Yee J.D., et al. Patient-controlled analgesia in children and adolescents: a randomized, prospective comparison with intramuscular administration of morphine for postoperative analgesia. J Pediatr 118 3 (1991) 460-466
110. Cherney N.I., and Foley K.M. Nonopioid and opioid analgesics in pharmacotherapy. Hematol Oncol Clin North Am 10 1 (1996) 79-102
111. Indelicato R.A., and Portenoy R.K. Opioid rotation in the management of refractory cancer pain. J Clin Oncol 21 (2003) 87-91
112. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 3 (2004) CD004847
113. Drake R., Longworth J., and Collins J.J. Opioid rotation in children with cancer. J Palliat Med 7 3 (2004) 419-422
114. Inturrisi C.E., Portenoy R.K., Max M.B., et al. Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther 47 5 (1990) 565-577
115. Manfredi P.L., and Houde R.W. Prescribing methadonea unique analgesic. J Support Oncol 1 3 (2003) 216-220
116. Maxwell L.G., Kaufmann S.C., Bitzer S., et al. The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study. Anesth Analg 100 4 (2005) 953-958
117. Kenny N.P., and Frager G. Refractory symptoms and terminal sedation of children: ethical issues and practical management. J Palliat Care 12 3 (1996) 40-45